An App Responding to Behaviour of People to Promote Mental Wellbeing in Anxious Youth
SMILE
1 other identifier
interventional
101
1 country
1
Brief Summary
The goal of this clinical trial is to utilize mobile-sensing techniques to produce and test a simplified and personalized treatment app, Smile for Life (SMILE), for youth diagnosed with an anxiety disorder. The main questions it aims to answer are:
- Complete an online survey on emotional well-being and personality traits at the beginning and end of the one-month study, as well as at the 3-month follow-up. Participants will receive daily notifications asking participants to rate their social-emotional functioning. The app will then recommend a treatment plan and also ask participants to rate how helpful treatments were. Three months after the end of the study, participants will be asked to complete a follow-up assessment rating the app's usability.
- Participants in the intervention group will use a mobile app to practice cognitive behavioural therapy (CBT) treatment for their social-emotional issues.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Sep 2023
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 3, 2024
CompletedFirst Submitted
Initial submission to the registry
December 19, 2024
CompletedFirst Posted
Study publicly available on registry
December 27, 2024
CompletedJanuary 3, 2025
January 1, 2025
1 year
December 19, 2024
January 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety and sleep problems
Anxiety symptoms will be assessed using the 41-item SCARED questionnaire, where participants rate symptoms as not/hardly ever true (1), somewhat/sometimes true (2), or very/often true (3). Sleep problems will be assessed with the 7-item ISI, measuring difficulty falling/staying asleep and waking too early on a 5-point scale (0 = none, 4 = very severe). The ISI also evaluates sleep satisfaction, the noticeability of sleep issues, worry/distress about sleep, and their impact on daily functioning. Both tools will be administered pre- and post-intervention and at a three-month follow-up, providing comprehensive data on changes in anxiety and sleep problems over time. These measures will help determine the intervention's effectiveness in reducing anxiety and improving sleep quality.
One month
Study Arms (2)
SMILE Intervention Group
EXPERIMENTALThe intervention group used the SMILE App, and the Predicting Risk and Outcomes of Social InTerActions (PROSIT) app, which is a mobile sensing app.
Control Non-SMILE Intervention Group
NO INTERVENTIONParticipants in the control group downloaded and used only the PROSIT app, they did not use the SMILE App.
Interventions
The SMILE app, an iOS and Android compatible smartphone app, is based on effective CBT-based treatment features to help patients manage anxiety symptomology. Access requires a unique login. The SMILE app utilizes three relaxation features: calm breathing, mindfulness meditation, and deep muscle relaxation; one cognitive feature, thought journaling and the challenging of thoughts; one self-monitoring technique; a positive imagery game; and a feature aimed to reduce avoidance behaviour through exposure. The app will be self-guided, with no additional human involvement needed. Participants will be instructed to actively engage with at least one of the app's major functions for a minimum of 3 minutes per day.
Eligibility Criteria
You may qualify if:
- Ability to read, write, and speak English
- Aged 12-21
- Regular access to and usage of a smartphone
- Score \>25 on SCARED (25) (i.e., youth with anxiety disorders)
You may not qualify if:
- Other psychotherapy-based intervention
- Major medical illnesses which might impact participation (e.g., long periods of hospitalization)
- Youth who cannot provide informed consent (as this is a self-directed treatment program).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dalhousie University
Halifax, Nova Scotia, B3H 4R2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra M Meier, PhD
Dalhousie University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 19, 2024
First Posted
December 27, 2024
Study Start
September 19, 2023
Primary Completion
September 24, 2024
Study Completion
December 3, 2024
Last Updated
January 3, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
Participant data will be made available upon reasonable request to Dr. Sandra Meier (PI).